NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DermaSensor, Inc.

DermaSensor, Inc.

Private
Miami, FloridaHealthcare & Life Scienceshttps://www.dermasensor.com/

Last Round

Series B

Oct 2, 2025

Total Funding Raised

$43.31M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

DermaSensor, Inc. is a medical device company that has developed an FDA-cleared, AI-powered handheld device that uses optical spectroscopy to non-invasively assess suspicious skin lesions for melanoma, basal cell carcinoma, and squamous cell carcinoma.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

medical deviceskin cancer screeningAI-powered diagnosticsskin cancer detectionpoint of caredermatology AIclinical decision supportskin lesion assessmentspectroscopyFDA-clearedmedtechdigital healthAI dermatologymachine learningsubscription medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DermaSensor, Inc. Comparables

Compare DermaSensor, Inc. with similar companies based on industry and business-model similarity.

DermaSensor, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Veriskin
86%
MetaOptima Technology
78%
Scibase Holding
76%

DermaSensor, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 2, 2025
Series A ExtensionJun 15, 2022
Series AJun 4, 2020
Series A ExtensionDec 18, 2018

Key People

Founding team and executive leadership

Cody Simmons

CEO

Executive Team

Ryan Freiden

COO, VP Of Operations And Product

Executive Team

DermaSensor, Inc. Investors

Notable investors and investment history

DermaSensor, Inc. investors
InvestorRounds
SternAegis VenturesSeries A
Ceros Capital MarketsSeries A
Pier 70 VenturesSeries B
Kern Venture GroupSeries B
Ceros Capital MarketsSeries A Extension
Wealthing VC ClubSeries A Extension
Miami AngelsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased to 11, representing 31% of headcount.

  • Apr 17, 2026

    Monthly visitors increased 107% MoM.

DermaSensor, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DermaSensor, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DermaSensor, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida
Employee Range35
Year Founded2009
Last FundingOct 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.